Difference between revisions of "Part:pSB3K1"
Stefan Luzi (Talk | contribs) |
Stefan Luzi (Talk | contribs) |
||
| Line 5: | Line 5: | ||
[[Image:MapI739202.jpg|left|thumb|'''Fig. 1:''' Map of the pCK01BB1 plasmid|250px]][[Image:Mappcko1.jpg|right|thumb|'''Fig. 2:''' Map of the original pCK01 plasmid|250px]] | [[Image:MapI739202.jpg|left|thumb|'''Fig. 1:''' Map of the pCK01BB1 plasmid|250px]][[Image:Mappcko1.jpg|right|thumb|'''Fig. 2:''' Map of the original pCK01 plasmid|250px]] | ||
| − | In order to make this plasmid compatible with the [https://parts.igem.org/wiki/index.php/Assembly:Standard_assembly BioBrick Standard assembly process], the original pACYC177 was digested at its BamHI and PstI restriction sites and an appropriate multiple cloning site (MCS) was introduced in this position. However, this leads to a loss of the original ampicillin resistance and only kanamycin resistance is left.The term "BB1" in | + | In order to make this plasmid compatible with the [https://parts.igem.org/wiki/index.php/Assembly:Standard_assembly BioBrick Standard assembly process], the original pACYC177 was digested at its BamHI and PstI restriction sites and an appropriate multiple cloning site (MCS) was introduced in this position. However, this leads to a loss of the original ampicillin resistance and only kanamycin resistance is left. The term "BB1" in pACYC177BB1 refers to "BioBrick version 1". |
<br> | <br> | ||
===Purpose=== | ===Purpose=== | ||
| − | <p>This plasmid was designed for the [http://parts.mit.edu/igem07/index.php/ETHZ ETHZ iGEM 2007 project] and is used for the following BioBricks: [https://parts.igem.org/wiki/index.php/Part: | + | <p>This plasmid was designed for the [http://parts.mit.edu/igem07/index.php/ETHZ ETHZ iGEM 2007 project] and is used for the following BioBricks: [https://parts.igem.org/wiki/index.php/Part:BBa_I739006 ''Part 6''], [https://parts.igem.org/wiki/index.php/Part:BBa_I739007 ''Part 7''], [https://parts.igem.org/wiki/index.php/Part:BBa_I739010 ''Part 10''], [https://parts.igem.org/wiki/index.php/Part:BBa_I739011 ''Part 11''] and the composites [https://parts.igem.org/wiki/index.php/Part:BBa_I739018 BBa_I739018], [https://parts.igem.org/wiki/index.php/Part:BBa_I739019 BBa_I739019] and [https://parts.igem.org/wiki/index.php/Part:BBa_I739020 BBa_I739020]. More information on the plasmid and the used assembly strategy can be found [http://parts.mit.edu/igem07/index.php?title=ETHZ/Biology/Lab here]. |
</p><br> | </p><br> | ||
Revision as of 08:59, 25 October 2007
No part name specified with partinfo tag.
Plasmid pACYC177BB1 (Fig. 1) is based on pACYC177 (Fig. 2), a low-copy cloning vector (10-12 copies per cell) that confers ampicillin (ApR) and kanamycin (KmR) resistance and harbours the p15A origin of replication.
In order to make this plasmid compatible with the BioBrick Standard assembly process, the original pACYC177 was digested at its BamHI and PstI restriction sites and an appropriate multiple cloning site (MCS) was introduced in this position. However, this leads to a loss of the original ampicillin resistance and only kanamycin resistance is left. The term "BB1" in pACYC177BB1 refers to "BioBrick version 1".
Purpose
This plasmid was designed for the [http://parts.mit.edu/igem07/index.php/ETHZ ETHZ iGEM 2007 project] and is used for the following BioBricks: Part 6, Part 7, Part 10, Part 11 and the composites BBa_I739018, BBa_I739019 and BBa_I739020. More information on the plasmid and the used assembly strategy can be found [http://parts.mit.edu/igem07/index.php?title=ETHZ/Biology/Lab here].
Sequence and Features No part name specified with partinfo tag.